Literature DB >> 3379658

Clinical aspects of pyogenic liver abscess: the University Hospital of the West Indies experience.

A S Bansal1, P Prabhakar.   

Abstract

Twenty-four cases of pyogenic liver abscess admitted between 1977 and 1986 are presented. A mean age of 43 years (range 5-78) with a 3:1 male:female ratio and 25% mortality were noted. Fever and abdominal pain were encountered in over 80% of cases and anorexia and malaise in over 60%. Hepatomegaly and right upper quadrant tenderness were the commonest signs. Leucocytosis, raised alkaline phosphatase and gamma-glutamyl transpeptidase, and hypoalbuminaemia were each noted in roughly 80% of cases. None of these showed any prognostic significance. Predisposing factors were noted in 11 cases. No cases of associated biliary disease were noted. Multiple, polymicrobial, aerobic and mixed aerobic/anaerobic abscesses were associated with a higher mortality. Patients aged over 50 years or more also had a higher mortality (P less than 0.05). Anaerobic abscesses were often solitary and were associated with a lower mortality (P less than 0.05). Surgical drainage and guided percutaneous drainage showed no difference in morbidity.

Entities:  

Mesh:

Year:  1988        PMID: 3379658

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  4 in total

1.  Pyogenic liver abscess: multivariate analysis of risk factors.

Authors:  K T Lee; P C Sheen; J S Chen; C G Ker
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

2.  Gas-containing liver abscess: radiological findings and clinical significance.

Authors:  T Y Lee; Y L Wan; C C Tsai
Journal:  Abdom Imaging       Date:  1994 Jan-Feb

3.  A liver abscess presenting as bowel obstruction and perforation.

Authors:  Jan Rusman
Journal:  BMJ Case Rep       Date:  2013-04-22

4.  Pyogenic liver abscess: studies of therapy and analysis of risk factors.

Authors:  H J Mischinger; H Hauser; H Rabl; F Quehenberger; G Werkgartner; R Rubin; E Deu
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.